Document is current
Any future updates will be listed below
-
Authors
Schaefer, Robin http://orcid.org/0000-0003-4733-4692
Thomas, Ranjeeta
Robertson, Laura
Eaton, Jeffrey W.
Mushati, Phyllis
Nyamukapa, Constance
Hauck, Katharina
Gregson, Simon
-
Funding
Funding for this research was provided by:
Wellcome Trust
World Bank Group
UNICEF Zimbabwe
UK Medical Research Council
Department for International Development
- License Information
-
More Information
Article History
Received: 12 May 2020
Accepted: 8 October 2020
First Online: 23 October 2020
Ethics approval and consent to participate
: All procedures of this study were in accordance with the ethical approval granted by the Imperial College London Research Ethics Committee (ICREC_9_3_10 for the Manicaland Cash Transfer Trial; ICREC_9_3_13 for the Manicaland General-Population Cohort) and the Medical Research Council of Zimbabwe (MRCZ/A/1518 for the Manicaland Cash Transfer Trial; MRCZ/A/681 for the Manicaland General-Population Cohort). Informed consent was obtained in writing from all individual participants included in the study.
: Not applicable.
: S.G. declares shareholding in pharmaceutical companies (GSK and Astra Zeneca). R.T. declares personal fees received for consultancy for the International Decision Support Initiative. The authors declare no further potential competing interests.
